Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Biocon Ltd. Share Price
Day's Range
Day's Range
Low
₹434.50
High
₹441.60
Price Summary
| Previous Close | ₹440.30 |
|---|---|
| Day's Range | ₹434.50 - ₹441.60 |
| Open | ₹435.80 |
| 52 Week Range | ₹331.00 - ₹447.15 |
| Volume | 33,18,862 |
| Market Cap | ₹0.07 |
| Previous Close | ₹440.45 |
|---|---|
| Day's Range | ₹434.15 - ₹441.50 |
| Open | ₹434.15 |
| 52 Week Range | ₹331.00 - ₹447.00 |
| Volume | 86,915 |
| Market Cap | ₹0.07 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 14,595.48 |
|---|---|
| Market Cap (₹ in Mn) | 0.07 |
| Dividend Yield(%) | 0.11 |
| Price/Earning (TTM) | 186.15 |
| TTM EPS (₹) | 2.37 |
| P/E Ratio | 151.69 |
| Book Value(₹) | 2.14 |
| PAT Margin (%) | 2.17 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 3.26 |
| Trade Value ( ₹ in Lacs) | 382.03 |
|---|---|
| Market Cap (₹ in Mn) | 0.07 |
| Dividend Yield(%) | 0.11 |
| Price/Earning (TTM) | 186.15 |
| TTM EPS (₹) | 2.37 |
| P/E Ratio | 151.69 |
| Book Value(₹) | 2.14 |
| PAT Margin (%) | 2.17 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 3.26 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 6438.0 | 22426.0 |
| Expenses | N/A | N/A |
| PBT | 350.0 | 6609.0 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 212.0 | 6093.0 |
About Biocon Ltd.
| Founded | 1978 |
|---|---|
| Managing Director | Shreehas Pradeep Tambe |
| NSE Symbol | BIOCON |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,70,785.51 | 1,962.15 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,94,589.80 | 7,332.20 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,91,657.85 | 5,038.75 | 3,468.00 - 3,468.00 |
| Apollo Hospitals Enterprise Ltd. | 1,28,264.54 | 8,917.75 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,15,727.88 | 1,432.65 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,14,967.14 | 2,515.00 | 1,836.80 - 1,836.80 |
| Zydus Lifesciences Ltd. | 1,14,079.53 | 1,143.10 | 835.50 - 835.50 |
| Max Healthcare Institute Ltd. | 1,07,094.14 | 1,100.35 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,06,460.04 | 2,573.50 | 1,909.70 - 1,909.70 |
| Dr. Reddy's Laboratories Ltd. | 1,00,707.81 | 1,206.55 | 1,148.40 - 1,148.40 |
No Records Found
Latest News
Biocon informs about company statement
Biocon informs about AGM and annul report
Further to letter dated May 07, 2026, intimating that the 48th Annual General Meeting (‘AGM’) of the Company will be held on Thursday August 06, 2026 at 3:30 PM (IST) through Video Conferencing (‘VC’) / Other Audio Visual Means (‘OAVM’) in compliance with applicable provisions of the Companies Act, 2013 (‘the Act’) and rules made thereunder, the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) read with all applicable circulars on the matter issued by the Ministry of Corporate Affairs (‘MCA’) and the Securities and Exchange Board of India (‘SEBI’) and pursuant to the provisions of Regulation 30 and 34 of the SEBI Listing Regulations, Biocon has informed that it enclosed the Notice of 48th AGM and Integrated Annual Report (BRSR, GRI & ESG Data Book FY26 is a supplement to the Integrated Annual Report) of the Company for the Financial Year 2025-26. The same are also made available on the website of the Company at www.biocon.com. In compliance with the applicable Circulars issued by MCA and SEBI Listing Regulations, the Notice of the 48th AGM along with the Integrated Annual Report for the Financial Year 2025-26 are being sent only through electronic mode to those Members whose e-mail IDs are registered with the Registrar and Share Transfer Agents (‘RTA’) (in case of shares held in physical form) or with Depository Participants (‘DPs’) (in case of shares held in demat form). Further, pursuant to Regulation 36(1)(b) of SEBI Listing Regulations, the Company has also sent letter containing the weblink along with the path and QR Code to access the Notice of the 48th AGM and Integrated Annual Report of the Company for Financial Year 2025-2026, to those Members who have not registered their e-mail IDs with the RTA or with the DPs. Copy of the said letter is enclosed.
The above information is a part of company’s filings submitted to BSE.
Biocon informs about AGM
Biocon informs about disclosure
Biocon informs about press release
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Biocon Ltd. is ₹440.30 as of 2026-07-21.
The market capitalisation of Biocon Ltd. is ₹71,779.88 as of 2026-07-21.
The 1-year return of Biocon Ltd. is 45.65% as of 2026-07-21.
The P/E ratio of Biocon Ltd. is 151.69 as of 2026-07-22.
The 52-week high and low of Biocon Ltd. are ₹447.15 and ₹331.00, respectively, as of 2026-07-21.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
